| |
| |
|
| Insider
Information: |
Smith Ian F |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
267,823 |
|
|
Indirect Shares
|
5,306 |
|
|
| Direct
Value |
$22,116,413 |
|
|
|
Indirect Value
|
$2,416,034 |
|
|
| Total
Shares |
273,129 |
|
|
| Total
Value |
$24,532,447 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Vertex Pharmaceuticals Inc |
VRTX |
EVP, COO |
2018-06-29 |
46,699 |
2018-06-29 |
5,306 |
Premium* |
|
|
Acorda Therapeutics Inc |
ACOR |
Director |
2018-06-15 |
0 |
2016-01-04 |
0 |
Premium* |
|
|
Infinity Pharmaceuticals Inc |
INFI |
Director |
2018-06-12 |
45,845 |
2017-05-25 |
0 |
Premium* |
|
|
Solid Biosciences Inc |
SLDB |
|
2024-04-03 |
103,207 |
2020-12-10 |
0 |
Premium* |
|
|
Foghorn Therapeutics Inc. |
FHTX |
|
2021-04-27 |
72,072 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2003-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,920 |
1,920 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2004-03-17 |
4 |
A |
$0.01 |
$29 |
D/D |
2,880 |
4,800 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2004-05-06 |
4 |
A |
$0.01 |
$650 |
D/D |
65,000 |
69,800 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
SVP & CFO |
• – – |
2005-02-03 |
4 |
A |
$0.01 |
$57 |
D/D |
5,700 |
75,500 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2005-12-16 |
4 |
S |
$27.64 |
$326,503 |
D/D |
(11,811) |
70,250 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2005-12-21 |
4/A |
S |
$27.88 |
$329,291 |
D/D |
(11,811) |
70,250 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-23 |
4 |
AS |
$33.64 |
$889,172 |
D/D |
(26,432) |
70,250 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-01-23 |
4 |
OE |
$15.60 |
$415,593 |
D/D |
26,432 |
84,631 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
officerTitle |
• – – |
2006-02-02 |
4 |
A |
$0.01 |
$122 |
D/D |
12,200 |
82,450 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-02-22 |
4 |
AS |
$37.77 |
$427,028 |
D/D |
(11,306) |
82,450 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-02-22 |
4 |
OE |
$15.60 |
$177,784 |
D/D |
11,306 |
88,534 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-03-20 |
4 |
AS |
$40.12 |
$57,773 |
D/D |
(1,440) |
81,010 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-03-22 |
4 |
OE |
$15.60 |
$177,815 |
D/D |
11,308 |
87,096 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-03-22 |
4 |
AS |
$37.81 |
$427,555 |
D/D |
(11,308) |
81,010 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-04-24 |
4 |
AS |
$38.31 |
$146,344 |
D/D |
(3,820) |
81,010 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-04-24 |
4 |
OE |
$15.60 |
$60,026 |
D/D |
3,820 |
83,223 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-05-17 |
4 |
AS |
$31.47 |
$61,839 |
D/D |
(1,965) |
81,010 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-07-24 |
4 |
AS |
$34.96 |
$133,547 |
D/D |
(3,820) |
81,010 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-07-24 |
4 |
OE |
$15.60 |
$60,026 |
D/D |
3,820 |
84,830 |
|
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-10-23 |
4 |
AS |
$33.65 |
$128,543 |
D/D |
(3,820) |
81,010 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-10-23 |
4 |
OE |
$15.60 |
$60,026 |
D/D |
3,820 |
84,830 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2006-12-13 |
4 |
AS |
$38.55 |
$18,504 |
D/D |
(480) |
80,530 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-01-24 |
4 |
A |
$0.01 |
$321 |
D/D |
32,084 |
112,614 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-05-07 |
4 |
AS |
$30.61 |
$994,825 |
D/D |
(32,500) |
80,114 |
0 |
- |
|
| VRTX |
Vertex Pharmaceuticals In... |
EVP & CFO |
• – – |
2007-05-17 |
4 |
AS |
$31.95 |
$26,295 |
D/D |
(823) |
80,114 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
